Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

32 results about "Medication abuse" patented technology

Medetomidine hapten and preparation method thereof, medetomidine antigen and preparation method thereof, kit and medetomidine detection method

The invention relates to the technical field of biochemical engineering, in particular to a medetomidine hapten, a preparation method of the medetomidine hapten, a medetomidine antigen, a preparation method of the medetomidine antigen, a kit and a medetomidine detection method. The medetomidine hapten is selected from a compound shown in the following structural formula: # imgabs0 #, q is any integer between 1 and 5, and R represents amido or carbonyl. The medetomidine hapten can be used for synthesizing a medetomidine antigen, so that the medetomidine hapten can be used for immunizing to generate an antibody, and adverse reaction caused by using medetomidine or hydrochloride thereof is reduced. Meanwhile, the medetomidine can be applied to rapid diagnosis products such as kits, medetomidine can be simply, conveniently and rapidly detected, and then the phenomenon of drug abuse can be effectively reduced.
Owner:SURE BIOTECH (HANGZHOU) LTD

Point-of-collection graphene-based toxicology sensor

In one aspect, a sensor for detecting a drug of abuse (DOA) in a sample is disclosed. In some embodiments, the sensor includes a graphene layer, a plurality of binding agents, which bind to the DOA, coupled to said graphene layer to generate a functionalized graphene layer, and a plurality of electrical conductors electrically coupled to said functionalized graphene layer for measuring an electrical property of said functionalized graphene layer. While in some embodiments, such binding agents are monoclonal antibodies, in other embodiments they are polyclonal antibodies.
Owner:GRAPHENE DX INC

Sample pad processing method for drug abuse detection, detection method and chromatographic test paper

ActiveCN119438569Ahigh sensitivityBiological testingBiochemistrySubstance Abuse Detection
The invention relates to the technical field of immunochromatography, in particular to a sample pad processing method for drug abuse detection, a detection method and chromatography test paper. According to the present invention, the sample pad treatment liquid of the immunochromatography test paper for drug abuse detection is innovated, such that the Pluronic F-127-containing sample pad treatment liquid is adopted to treat the sample pad so as to significantly improve the drug abuse item detection sensitivity of the immunochromatography test paper;
Owner:GUANGDONG FAPON BIOTECH CO LTD

Compounds for treating psychostimulant misuse

Described herein are new dual sigma receptor and dopamine transporter small molecule antagonists. As these compounds are antagonists of both sigma receptors and dopamine transporters, these compounds dose-dependently antagonize stimulant self-administration and also diminish the effects of stimulant effects on dopamine level, thus indicating minimal abuse liability.
Owner:UNIV OF FLORIDA RESEARCH FOUNDATION INC

Preparation of abuse-deterrent pharmaceutical formulations using vapor phase deposition

The disclosure is directed at an abuse-deterrent pharmaceutical composition comprising a coated antagonist particle, and the use thereof for preventing or minimizing the risk of opioid abuse and / or opioid toxicity from either intentional or unintentional tampering. Methods for manufacturing such an abuse-deterrent pharmaceutical composition are also provided.
Owner:APPLIED MATERIALS INC

A method for treating a neurological disease in a recreational drug user

The present disclosure relates to the method of treating neurological disease in a recreational drug user by administering an effective amount of soticlestat or a pharmaceutically acceptable salt thereof, wherein the treatment does not produce the potential of drug abuse.
Owner:TAKEDA PHARMA CO LTD

Sample pad treatment method, detection method and chromatographic test strip for drug abuse detection

ActiveCN119438569Bhigh sensitivityBiological testingBiochemistrySubstance Abuse Detection
The present application relates to the field of immunochromatography, in particular to a sample pad treatment method, a detection method and a chromatography test paper for drug abuse detection, and discloses an immunochromatography test paper for drug abuse detection, which is characterized by a sample pad treatment liquid containing Pluronic F-127.
Owner:GUANGDONG FAPON BIOTECH CO LTD

Application of substance specifically binding to S-100B protein in preparation of diagnosis product or prognosis product for acute retinal necrosis

The invention relates to the field of medicine, in particular to application of a substance specifically binding to S-100B protein to preparation of an acute retinal necrosis diagnosis product or prognosis product. By detecting the level of S-100B protein in aqueous humor, the condition of optic nerve injury caused by acute retinal necrosis can be objectively and accurately observed, clinical early diagnosis of ARN can be helped, a correct treatment method can be adopted in time, the risk of retinal detachment and blindness can be effectively reduced, clinical prediction of disease development and vision prognosis can be helped, early intervention can be realized, and clinical diagnosis of acute retinal necrosis can be realized. Accurate treatment is achieved, and medicine abuse and waste of medical resources are reduced.
Owner:EYE & ENT HOSPITAL SHANGHAI MEDICAL SCHOOL FUDAN UNIV

Scientific education device suitable for performing medicine abuse hazard theme

The invention provides a science and education device suitable for a subject of drug abuse harm. The science and education device comprises a vertical plate; a housing for representing a human body; the first pipeline is provided with an inlet end and an outlet end which extend to the rear of the shell; the first branch pipe, the second branch pipe and the third branch pipe are converged and communicated to the gathering pipeline; balls for representing different medicines and telescopic rods for suspending the balls in the corresponding branch pipes are mounted in the first branch pipe, the second branch pipe and the third branch pipe respectively; a blower; the rotating elbow can rotate in a vertical plane, so that a bottom outlet of the rotating elbow can be respectively aligned with top end openings of the first branch pipe, the second branch pipe and the third branch pipe; a first switch, a second switch and a third switch; the control device is used for controlling the telescopic rods in the corresponding branch pipes to be in a contraction state when the switches are triggered, driving the air blowers to start and controlling the rotating elbows to rotate so that bottom outlets of the rotating elbows can be aligned to top end openings of the corresponding branch pipes. The science and education device provided by the invention is good in display effect.
Owner:NAT CULTURAL & CREATIVE (BEIJING) CULTURE TECH CO LTD

Vapor phase coating technology for pharmaceutical abuse deterrent formulations

A method of preparing an abuse deterrent pharmaceutical composition having a drug-containing core enclosed by one or more metal oxide materials is provided. The method includes the sequential steps of (a) loading the particles comprising the drug into a reactor, (b) applying a vaporous or gaseous metal precursor to the particles in the reactor, (c) performing one or more pump-purge cycles of the reactor using inert gas, (d) applying a vaporous or gaseous oxidant to the particles in the reactor, and (e) performing one or more pump-purge cycles of the reactor using inert gas. This produces an abuse deterrent pharmaceutical composition comprising a drug containing core enclosed by one or more metal oxide materials.
Owner:APPLIED MATERIALS INC

Intelligent management system of medical information data based on blockchain

The present application provides an intelligent management system for medical information data based on blockchain, which relates to the field of medical information management technology. The system includes: a medical information download module for downloading medical information; a tracking track introduction module for introducing multiple medical resource tracking tracks; a digital certificate addition module for adding non-homogeneous digital certificates; an access authorization opening module for creating an access permission list reserved for the user terminal corresponding to the target user; a model building module for establishing a medical over-analysis model; and a data collaborative management module for collaborative data management of medical information. This application can solve the technical problems of increased bacterial resistance and waste of medical resources due to the abuse and insufficient monitoring of key drugs such as antibiotics in medical resource management, and achieve the technical effect of improving the rationality of medical resource allocation and reducing the risk of drug resistance by establishing a data-driven medical over-analysis model.
Owner:JIANGSU AIXING INFORMATION TECH CO LTD

System, Method, and Computer Program Product for Detecting Fluid Flow Through Ultrasonic Flow Sensors and / or Identifying Medication Diversion

PendingUS20250332344A1Medical data miningDrug and medicationsIdentifying medicationsPharmacy medicine
Systems, methods, and computer program products are provided for detecting fluid flow through ultrasonic flow sensors and / or identifying medication diversion. An example system includes at least one processor configured to: generate, using at least one machine learning model, based on a time-series generated by an ultrasonic flow sensor, a predicted start time associated with a start of a flow, a predicted time period associated with the flow, and / or a predicted end time associated with an end of the flow; and / or identify, based on the time-series, in a database, at least one stored feature representation associated with at least one medication type.
Owner:BECTON DICKINSON & CO

Determination method of 3-hydroxypropyl nortadalafil

The invention provides a determination method of 3-hydroxypropyl nortadalafil, which comprises the following steps: weighing a 3-hydroxypropyl nortadalafil sample, adding a methanol solution, dissolving with methanol, fixing the volume, and preparing a standard stock solution; taking a proper amount of standard stock solution, diluting with a methanol-water solution, and preparing a standard working solution; transferring into a centrifugal tube for centrifugal treatment; filtering the supernate through a microfiltration membrane, and taking a subsequent filtrate; taking a proper amount of the standard working solution, injecting the standard working solution into a high performance liquid chromatography-tandem mass spectrometer, and recording a chromatogram and a mass spectrum; and sequentially injecting the series of standard working solutions into a high performance liquid chromatography-tandem mass spectrometer, and drawing a standard curve. According to the present invention, the blank of the ultra-high performance liquid chromatography-tandem mass spectrometry detection method for the 3-hydroxypropyl nortadalafil is filled, the detection basis is provided for ensuring the food safety law enforcement method, the drug abuse risk is avoided, and the food quality is ensured to meet the standard.
Owner:XIAMEN ZHONGJIXIN TESTING TECH CO LTD

Apparatus, system and method for processing medical data and image data in a computer system

ActiveUS12469586B1Drug and medicationsMedical automated diagnosisPrescription Drug Monitoring ProgramPharmacy medicine
Technologies and techniques for processing drug data in a computer network. Data from a prescription drug monitoring program (PDMP) and medical / prescription data is received for a patient. Image data of the one or more patients is also received from an image capturing device. The PDMP data, medical data and image data is processed to predictably determining a potential drug abuse condition in one of the one or more patients, wherein the predictive determination includes detecting one or more facial emotive expressions from the image data. A file including data relating to the drug abuse condition may be generated and transmitted to the computer network.
Owner:ALLSCRIPTS SOFTWARE LLC

Composition and method for in vivo assay of opioid receptors

Compositions and methods are provided to determine occupancy level of opioid receptors in a subject. The disclosed methods may be performed non-invasively in the inner ear of the subject, and may be performed at a point-of-care location to provide guidance to a practitioner on tapering on pharmacotherapy or on a patient's risk of relapse for substance abuse.
Owner:TRUSTEES OF DARTMOUTH COLLEGE THE

Orally disintegrating pharmaceutical tablet containing cariprazine

An orally disintegrating pharmaceutical tablet comprising: between 0.1 and 21 wt % of cariprazine or its pharmaceutically acceptable salts, between 0.1 and 15 wt % of a disintegrant, between 0.1 and 5 wt % of colloidal silicon dioxide, between 0.1 and 10 wt % of a taste masking agent, between 0.1 and 5 wt % of a lubricant, and up to 100 wt % of a diluent, the percentage being expressed with regard to the total weight of the pharmaceutical tablet. Said composition for use in the treatment and / or prevention of pathological conditions which require the modulation of dopamine receptors, selected from the group of psychoses, drug abuse, cognitive impairment accompanying schizophrenia, mild-to-moderate cognitive deficits, dementia, psychotic states associated with dementia, eating disorders, attention deficit disorders, hyperactivity disorders in children, psychotic depression, bipolar disorder, paranoid and delusional disorders, dyskinetic disorders, anxiety, sexual dysfunction, sleep disorders, emesis, aggression and autism.
Owner:RICHTER GEDEON NYRT

PRECISION DISTRIBUTION DEVICE FOR LIQUIDS, INCLUDING A DEVICE FOR REMOTE CONTROL AND MONITORING

UndeterminedCY1126273T1Pharmacy medicineRemote control
A precision dispensing device for liquids, including a device for remote control and monitoring. A dispensing device for liquids, more particularly pharmaceutical compositions, is described that allows remote control for all functions associated with dispensing the drug to the patient so as to prevent abuse. The dispensing device includes a contact or contactless reader, a GPS sensor, and a biometric sensor such as a fingerprint and facial recognition sensor. The dispensing device is connected to the Internet.
Owner:L MOLTENI & C DEI FRAT ALITTI SOC DI ESERCIZIO SPA

Orally disintegrating pharmaceutical tablet containing cariprazine

The present invention relates to an orally disintegrating pharmaceutical tablet comprising between 0.1 and 21% by weight of cariprazine or a pharmaceutically acceptable salt thereof, between 0.1 and 15% by weight of a disintegrating agent, between 0.1 and 5% by weight of colloidal silica, between 0.1 and 10% by weight of a taste masking agent, between 0.1 and 5% by weight of a lubricant, and up to 100% by weight of a diluent, the percentage being expressed relative to the total weight of the pharmaceutical tablet. The present invention relates to a composition for use in the treatment and / or prevention of pathological conditions requiring modulation of dopamine receptors, the composition is selected from the group consisting of psychosis, drug abuse, cognitive impairment associated with schizophrenia, mild to moderate cognitive deficits, dementia, psychotic states associated with dementia, eating disorders, attention deficit disorders, hyperactivity disorders in children, psychotic depression, bipolar disorders, paranotic and delusional disorders, dyskinesia, anxiety, sexual dysfunction, sleep disorders, vomiting, or the like. And attacking behaviors and autism.
Owner:RICHTER GEDEON NYRT

Drug screening reagent card

1. The name of the design product: drug screening reagent card. 2. The use of the design product: used for qualitative detection of specific drug components in human urine samples to screen for drug abuse. 3. The design points of the design product: the combination of shape, pattern and color. 4. The picture or photo that best indicates the design points: combination state diagram. 5. The design for which protection is sought contains color.
Owner:ATLAS LINK TECH CO LTD

OXADIAZASPIRIDE COMPOUNDS FOR THE TREATMENT OF DRUG ABUSE AND ADDICTION

UndeterminedCY1125668T1ReceptorMedicinal chemistry
The present invention relates to compounds having pharmacological activity against the sigma (σ) receptor, and more particularly to oxadiazaspiro compounds having this pharmacological activity, to methods of preparing such compounds, to pharmacological compositions comprising them and to their use in therapy, in particular against drug abuse and addiction.
Owner:ESTEVE FARMASYUTIKALZ S A

Pharmacological phenotype prediction platform for individuals and queues

The application relates to a computing device for identifying pharmacological phenotypes. Pharmacological phenotypes are predicted for patients who exhibit or are likely to exhibit a primary disease or complication. A machine learning engine may generate statistical models based on training data from a trained patient to predict pharmacological phenotypes, including drug responses and doses, drug adverse events, risk of diseases and complications, drug-gene interactions, drug-drug interactions, and multi-pharmacy interactions. The model can then predict the pharmacological phenotype of a new patient and can make decisions in clinical and research contexts, including drug selection and dosage, changes in drug treatment regimens, multi-pharmacy optimization, monitoring, and the like, to benefit from additional predictive capabilities, as well as to improve the ability to predict the pharmacological phenotype of the new patient. Therefore, adverse events and drug abuse are avoided, drug response is improved, patient recovery results are improved, treatment cost is reduced, public health benefits are improved, and research efficiency in pharmacology and other biomedical fields is improved.
Owner:THE RGT UNIV OF MICHIGAN

Formulations comprising a denatonium salt for preventing malicious drug use

Provided herein are pharmaceutical compositions comprising a denatonium salt and a pharmaceutical agent. Also provided herein are methods for reducing a risk of drug abuse comprising use of a denatonium salt to decrease the likelihood of improper ingestion of a pharmaceutical agent. Also provided herein are methods for making the test of a drug less palatable comprising a subclinical dose of a denatonium salt.
Owner:AARDVARK THERAPEUTICS INC

Diversion detection system

To provide a diversion detection system, a method, a device, and a storage medium for preventing diversion of a medicine.SOLUTION: A method for generating evidence of a diversion event includes detection of a trigger event in a medicine preparation cabinet including a medicine (702). The method includes activation of one or multiple monitoring devices so as to acquire a record according to detection of a trigger event (704). The record includes an event that is suspected of diversion. The method includes generation of one or multiple transaction records related to the record (706). The method includes filtering of multiple records on the basis of one or multiple transaction records in a database (712). The multiple records include a record for specifying whether an event suspected of diversion occurs. According to specification (714) of occurrence of an event suspected of diversion, the method includes generation of an alert showing occurrence of the event suspected of diversion (716).SELECTED DRAWING: Figure 7
Owner:CAREFUSION 303 INC

Vsg-based vaccination and antibody generation platform for the treatment of diseases

The invention is based on a platform for vaccination and / or antibody generation. The invention is based on the display of small molecular immunogenic compounds on the coat of variant surface glycoproteins (VSG) on trypanosomes which results in a highly effective immune response when used as a vaccine or in immunization for antibody production. The herein disclosed antigenic particles are applicable for producing antibodies or can be directly used as vaccines for the treatment of various medical conditions. Most preferably the invention relates to the VSG based vaccines specific for dependency causing substances for the treatment of addiction or avoidance of adverse events during drug abuse. Other applications include methods and uses involving the disclosed compounds and compositions for a treatment or prevention of cancer, infectious disease, contagious neurodegenerative diseases, non-communicable disorders (e.g. certain neurodegenerative diseases, allergies) and any condition or industrial use for which an immune response from vaccination or antibody use would be desirable.
Owner:DEUTES KREBSFORSCHUNGSZENT STIFTUNG DES OFFENTLICHEN RECHTS

Preparation of abuse-deterrent pharmaceutical formulations using vapor phase deposition

The disclosure is directed at an abuse-deterrent pharmaceutical composition comprising a coated antagonist particle, and the use thereof for preventing or minimizing the risk of opioid abuse and / or opioid toxicity from either intentional or unintentional tampering. Methods for manufacturing such an abuse-deterrent pharmaceutical composition are also provided.
Owner:APPLIED MATERIALS INC

Use of substances that specifically bind to the S-100B protein in the preparation of diagnostic or prognostic products for acute retinal necrosis.

ActiveCN119619524BSenses disorderMicrobiological testing/measurementDetached retinaRetinal necrosis
This invention relates to the pharmaceutical field, and particularly to the use of substances that specifically bind to S-100B protein in the preparation of diagnostic or prognostic products for acute retinal necrosis (ARN). By detecting the level of S-100B protein in the aqueous humor, the extent of optic nerve damage caused by ARN can be objectively and accurately observed. This can aid in the early clinical diagnosis of ARN, enabling timely and appropriate treatment, effectively reducing the risk of retinal detachment and blindness, and helping clinicians predict disease progression and visual prognosis, achieving early intervention, precision treatment, and reducing drug abuse and waste of medical resources.
Owner:EYE & ENT HOSPITAL SHANGHAI MEDICAL SCHOOL FUDAN UNIV